Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

Author： McKeage Kate   Lyseng-Williamson Katherine A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.8, 2010-08, pp. : 687-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel: A Pharmacoeconomic Review of its Use in Patients with Non-ST Elevation Acute Coronary Syndromes

By Lyseng-Williamson Katherine A.   Plosker Greg L.  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 709-726

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Fondaparinux in Non-ST-Elevation Acute Coronary Syndrome

By Latour-Perez Jaime   de-Miguel-Balsa Eva  

PharmacoEconomics, Vol. 27, Iss. 7, 2009-07 ,pp. : 585-595

Adis International

Access to resources Recommend Favorite

Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes

By Galla John M   Mahaffey Kenneth W  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite

Fondaparinux Sodium: A Review of its Use in the Management of Acute Coronary Syndromes

By Blick Stephanie K.A.   Orman Jennifer S.   Wagstaff Antona J.   Scott Lesley J.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 2, 2008-01 ,pp. : 113-125

Adis International

Access to resources Recommend Favorite

Antithrombotic Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes: Recommendations of the Rio de la Plata Expert Panel

By  

Clinical Drug Investigation, Vol. 19, Iss. 6, 2000-06 ,pp. : 409-420

Adis International

Access to resources Recommend Favorite